Investors & Media

Company Profile

Business Description

We are a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological disease. Our zinc finger epigenetic regulators are ideally suited to potentially address devastating neurology disorders and our capsid discovery platform is making progress toward potentially expanding delivery beyond currently available intrathecal delivery capsids, including in the central nervous system.

Headquarters

501 Canal Blvd, Richmond, CA 94804

 


Industry Classifications

Sector
Healthcare
Industry
Biotechnology
NAICS
Biological Product (Except Diagnostic) Manufacturing (325414)
SIC
Biological Products, Except Diagnostic Substances (2836)

Stock Information
Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Historical Lookup

Week of July 22, 2024

Date Requested Closing Price Volume Split Adjustment Factor Open Price Day High Day Low
July 22, 2024 $0.40 811,538 1:1 $0.39 $0.42 $0.37
July 23, 2024 $0.40 461,637 1:1 $0.40 $0.42 $0.39

Contacts